ReacX Pharmaceuticals, Inc.
PrivateLast Round
Grant
Feb 5, 2025
Company Overview
ReacX Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in South San Francisco, California. It was founded in 2020.
ReacX Pharmaceuticals, Inc. is a biotechnology company that develops therapeutics using its proprietary ProNeura drug delivery technology for the treatment of chronic conditions such as opioid addiction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReacX Pharmaceuticals, Inc. Comparables
Compare ReacX Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Akyso Therapeutics | 87% | |
| Hera Health Solutions | 85% | |
| Delpor | 84% |
For institutional investors. Book with your work email.
ReacX Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
ReacX Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2025
$10.35M grant received from National Institute on Drug Abuse.
For institutional investors. Book with your work email.
ReacX Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReacX Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is ReacX Pharmaceuticals, Inc. a public or private company?
ReacX Pharmaceuticals, Inc. is a private company.
What is the current stock price of ReacX Pharmaceuticals, Inc.?
ReacX Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks ReacX Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReacX Pharmaceuticals, Inc. worth (valuation)?
Valuation information for ReacX Pharmaceuticals, Inc. is not publicly available.
Can I buy ReacX Pharmaceuticals, Inc. stock?
ReacX Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReacX Pharmaceuticals, Inc.'s last funding round?
ReacX Pharmaceuticals, Inc.'s most recent funding round was Grant on February 5, 2025.
Who are the main investors in ReacX Pharmaceuticals, Inc.?
Key investors in ReacX Pharmaceuticals, Inc. include National Institute on Drug Abuse.
Will ReacX Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for ReacX Pharmaceuticals, Inc..
How can I track ReacX Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ReacX Pharmaceuticals, Inc.'s shares on secondary markets.